Optic nerve sheath fenestration vs cerebrospinal diversion procedures: What is the preferred surgical procedure for the treatment of idiopathic intracranial hypertension failing maximum medical therapy?

Journal of Neuro-Ophthalmology

Volumn 33, Issue 2, 2013, Pages 183-188

  Spitze, Arielle ^a   Malik, Amina ^b   Al Zubidi, Nagham ^a   Golnik, Karl ^b,c   Lee, Andrew G ^a,d,e,f,g  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c CINCINNATI EYE INSTITUTE   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^f BAYLOR COLLEGE OF MEDICINE   (United States)

^g University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE;

ARTICLE; BRAIN VENTRICLE PERITONEUM SHUNT; CEREBROSPINAL FLUID DRAINAGE; CEREBROSPINAL FLUID SHUNTING; DRUG TREATMENT FAILURE; HEADACHE; HUMAN; IDIOPATHIC INTRACRANIAL HYPERTENSION; INTERMETHOD COMPARISON; LUMBAR PUNCTURE; LUMBOPERITONEAL SHUNT; MORBIDITY; MORTALITY; OPTIC NERVE SHEATH FENESTRATION; PAPILLEDEMA; PATIENT PREFERENCE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REOPERATION; SURGICAL TECHNIQUE; VENTRICULOATRIAL SHUNT; VISION; VISUAL ACUITY; VISUAL FIELD; VISUAL IMPAIRMENT; WEIGHT REDUCTION;

HUMANS; MYELIN SHEATH; OPTIC NERVE DISEASES; PSEUDOTUMOR CEREBRI;

EID: 84879992434     PISSN: 10708022     EISSN: 15365166     Source Type: Journal    
DOI: 10.1097/WNO.0b013e318292d06f     Document Type: Article

References (37)

1. Hamdallah I, Shamseddeen H, Getty J, Smith W, Ali M. Greater than expected prevalence of pseudotumor cerebri: a prospective study. Surg Obes Relat Dis. 2013; 9:77-82.
2. Shaw G, Million S. Benign intracranial hypertension: a diagnostic dilemma. Case Rep Otolaryngol. 2012;2012:814696.
3. Biousse V, Rucker J, Vignal C, Crassard I, Katz B, Newman N. Anemia and papilledema. Am J Ophthalmol. 2003;135:437-446.
4. Friedman D, Jacobson D. Diagnostic criteria for idiopathic intracranial hypertension. Neurology. 2002;59:1492-1495.
5. Ahmed R, Friedman DI, Halmagyi GM. Stenting of the transverse sinuses in idiopathic intracranial hypertension. J Neuroophthalmol. 2011;31:374-380.
6. Friesner D, Rosenman R, Lobb B, Tanne E. Idiopathic intracranial hypertension in the USA: the role of obesity in establishing prevalence and healthcare costs. Obes Rev. 2011;12:e372-380.
7. Biousse V, Bruce B, Newman N. Update on the pathophysiology and management of idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry. 2012;83:488-494.
8. Binder D, Horton J, Lawton M, McDermott M. Idiopathic intracranial hypertension. Neurosurgery. 2004;54:538-551.
9. Uretsky S. Surgical interventions for idiopathic intracranial hypertension. Curr Opin Ophthalmol. 2009;20:451-4455.
10. Banta J, Farris B. Pseudotumor cerebri and optic nerve sheath decompression. Ophthalmology. 2000;107:1907-1912.
11. Chandrasekaran S, McCluskey P, Minassian D, Assaad N. Visual outcomes for optic nerve sheath fenestration in pseudotumour cerebri and related conditions. Clin Experiment Ophthalmol. 2006;34:661-665.
12. Spoor T, McHenry J. Long term effectiveness of optic nerve sheath decompression for pseudotumor cerebri. Arch Ophthalmol. 1993;111:632-935.
13. Alsuhaibani A, Carter K, Nerad J, Lee A. Effect of optic nerve sheath fenestration on papilledema of the operated and the contralateral nonoperated eyes in idiopathic intracranial hypertension. Ophthalmology. 2011;118:412-414.
14. Feldon S. Visual outcomes comparing surgical techniques for management of severe idiopathic intracranial hypertension. Neurosurg Focus. 2007;23:E6.
15. Brazis P. Clinical review: the surgical treatment of idiopathic pseudotumor cerebri (idiopathic intracranial hypertension). Cephalalgia. 2008;28:1361-1373.
16. Wall M. Idiopathic intracranial hypertension (pseudotumor cerebri). Curr Neurol Neurosci Rep. 2008;8:87-93.
17. Corbett J, Nerad J, Tse D, Anderson R. Results of optic nerve sheath fenestration for pseudotumor cerebri. The lateral orbitotomy approach. Arch Ophthalmol. 1988;106:1391-1397.
18. Pelton R. The anterior eyelid crease approach to the orbit. Curr Opin Ophthalmol. 2009;20:401-405.
19. Plotnik J, Kosmorsky G. Operative complications of optic nerve sheath decompression. Ophthalmology. 1993;100:683-690.
20. Mauriello J Jr, Shaderowfsky P, Gizzi M, Frohman L. Management of visual loss after optic nerve sheath decompression in patients with pseudotumor cerebri. Ophthalmology. 1995;102:441-445.
21. Karabatsou K, Quigley G, Buxton N, Foy P, Mallucci C. Lumboperitoneal shunts: are the complications acceptable? Acta Neurochir (Wien). 2004;146:1193-1197.
22. El-Saadany W, Farhoud A, Zidan I. Lumboperitoneal shunt for idiopathic intracranial hypertension: patients' selection and outcome. Neurosurg Rev. 2012;35:239-243.
23. Tarnaris A, Toma A, Watkins L, Kitchen N. Is there a difference in outcomes of patients with idiopathic intracranial hypertension with the choice of cerebrospinal fluid diversion site: a single centre experience. Clin Neurol Neurosurg. 2011;113:477-479.
24. Kandasamy J, Hayhurst C, Clark S, Jenkinson M, Byrne P, Karabatsou K, Mallucci C. Electromagnetic stereotactic ventriculoperitoneal CSF shunting for idiopathic intracranial hypertension: a successful step forward? World Neurosurg. 2011;75:155-160.
25. Curry W Jr, Butler W, Barker F II. Rapidly rising incidence of cerebrospinal fluid shunting procedures for idiopathic intracranial hypertension in the United States, 1988-2002. Neurosurgery. 2005;57:97-108.
26. Sinclair A, Kuruvath S, Sen D, Nightingale P, Burdon M, Flint G. Is cerebrospinal fluid shunting in idiopathic intracranial hypertension worthwhile? A 10-year review. Cephalalgia. 2011;31:1627-1633.
27. Friedman DI, Jacobson DM. Idiopathic intracranial hypertension. J Neuroophthalmol. 2004;24:138-145.
28. Burgett RA, Purvin VA, Kawasaki A. Lumboperitoneal shunting for pseudotumor cerebri. Neurology. 1997;49:734-739.
29. Eggenberger ER, Miller NR, Vitale S. Lumboperitoneal shunt for the treatment of pseudotumor cerebri. Neurology. 1996;46:1524-1530.
30. Angiari P, Corradini L, Corsi M, Merli GA. Pseudotumor cerebri: Lumboperitoneal shunt in long lasting cases. J Neurosurg Sci. 1992; 36:145-149.
31. McGirt MJ, Woodworth G, Thomas G, Miller N, Williams M, Rigamonti D. Cerebrospinal fluid shunt placement for pseudotumor cerebri-associated intractable headache: predictors of treatment response and an analysis of long-term outcomes. J Neurosurg. 2004;101:627-632.
32. Abubaker K, Ali Z, Raza K, Bolger C, Rawluk D, O'Brien D. Idiopathic intracranial hypertension: lumboperitoneal shunts vs ventriculoperitoneal shunts - case series and literature review. Br J Neurosurg. 2011;25:94-99.
33. Sergott RSavino P, Bosley T. Modified optic nerve sheath decompression provides long-term visual improvement for pseudotumor cerebri. Arch Ophthalmol. 1988;106:1384-1390.
34. Gellrich N, Stuehemer C, Bormann K, Mucke I, Schramm A, Eyesel UT, Rucker M. Degneration of retinal ganglion cells after optic nerve sheath fenestration in an experimental rat model. J Neuroophthalmol. 2009;29:275-280.
35. Acheson JF, Green WT, Sanders MD. Optic nerve sheath decompression for the treatment of visual failure in chronic raised intracranial pressure. J Neurol Neurosurg Psychiatry 1994;57:1426-1429.
36. Herzau V, Baykal HE. Long-term outcome of optic nerve sheath fenestration in pseudotumor cerebri. Klin Monatsbl Augenheilkd. 1998;213:154-160.
37. Cognard C, Casasco A, Toevi M, Houdart E, Chiras J, Merland JJ. Dural arteriovenous fistulas as a cause of intracranial hypertension due to impairment of cranial venous outflow. J Neurol Neurosurg Psychiatry. 1998;65:308-316.